Differentiation among Glioblastoma Multiforme, Solitary Metastatic Tumor, and Lymphoma Using Whole-Tumor Histogram Analysis of the Normalized Cerebral Blood Volume in Enhancing and Perienhancing Lesions

References

1. 1.↵
   1. Surawicz TS,
   2. McCarthy BJ,
   3. Kupelian V,
   4. et al

   . Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990–1994. Neuro Oncol 1999; 1: 14– 25

   Abstract/FREE Full Text
2. 2.↵
   1. Cha S,
   2. Lupo JM,
   3. Chen MH,
   4. et al

   . Differentiation of glioblastoma multiforme and single brain metastasis by peak height and percentage of signal intensity recovery derived from dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging. AJNR Am J Neuroradiol 2007; 28: 1078– 84

   Abstract/FREE Full Text
3. 3.↵
   1. Herrlinger U,
   2. Schabet M,
   3. Clemens M,
   4. et al

   . Clinical presentation and therapeutic outcome in 26 patients with primary CNS lymphoma. Acta Neurol Scand 1998; 97: 257– 64

   CrossRefPubMed
4. 4.↵
   1. Ling SM,
   2. Roach M,
   3. Larson DA,
   4. et al

   . Radiotherapy of primary central nervous system lymphoma in patients with and without human immunodeficiency virus: ten years of treatment experience at the University of California San Francisco. Cancer 1994; 73: 2570– 82

   CrossRefPubMed
5. 5.↵
   1. Reni M,
   2. Ferreri AJ,
   3. Garancini MP,
   4. et al

   . Therapeutic management of primary central nervous system lymphoma in immunocompetent patients: results of a critical review of the literature. Ann Oncol 1997; 8: 227– 34

   Abstract/FREE Full Text
6. 6.↵
   1. Cha S,
   2. Knopp EA,
   3. Johnson G,
   4. et al

   . Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002; 223: 11– 29

   CrossRefPubMedWeb of Science
7. 7.↵
   1. Wesseling P,
   2. Ruiter DJ,
   3. Burger PC

   . Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol 1997; 32: 253– 65

   CrossRefPubMed
8. 8.↵
   1. Jinnouchi T,
   2. Shibata S,
   3. Fukushima M,
   4. et al

   . Ultrastructure of capillary permeability in human brain tumor. Part 6. Metastatic brain tumor with brain edema [in Japanese]. No Shinkei Geka 1988; 16: 563– 68

   PubMed
9. 9.↵
   1. Aronen HJ,
   2. Gazit IE,
   3. Louis DN,
   4. et al

   . Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41– 51

   PubMedWeb of Science
10. 10.↵
    1. Knopp EA,
    2. Cha S,
    3. Johnson G,
    4. et al

    . Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211: 791– 98

    CrossRefPubMedWeb of Science
11. 11.↵
    1. Lev MH,
    2. Ozsunar Y,
    3. Henson JW,
    4. et al

    . Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligodendrogliomas. AJNR Am J Neuroradiol 2004; 25: 214– 21

    Abstract/FREE Full Text
12. 12.↵
    1. Law M,
    2. Cha S,
    3. Knopp EA,
    4. et al

    . High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 2002; 222: 715– 21

    PubMedWeb of Science
13. 13.↵
    1. Emblem KE,
    2. Nedregaard B,
    3. Nome T,
    4. et al

    . Glioma grading by using histogram analysis of blood volume heterogeneity from MR-derived cerebral blood volume maps. Radiology 2008; 247: 808– 17

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Law M,
    2. Young R,
    3. Babb J,
    4. et al

    . Histogram analysis versus region of interest analysis of dynamic susceptibility contrast perfusion MR imaging data in the grading of cerebral gliomas. AJNR Am J Neuroradiol 2007; 28: 761– 66

    Abstract/FREE Full Text
15. 15.↵
    1. Daumas-Duport C,
    2. Beuvon F,
    3. Varlet P,
    4. et al

    . Gliomas: WHO and Sainte-Anne Hospital classifications. Ann Pathol 2000; 20: 413– 28

    PubMedWeb of Science
16. 16.↵
    1. Rosen BR,
    2. Belliveau JW,
    3. Vevea JM,
    4. et al

    . Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14: 249– 65

    PubMedWeb of Science
17. 17.↵
    1. Ostergaard L,
    2. Weisskoff RM,
    3. Chesler DA,
    4. et al

    . High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. I. Mathematical approach and statistical analysis. Magn Reson Med 1996; 36: 715– 25

    CrossRefPubMedWeb of Science
18. 18.↵
    1. BoxermanJL,
    2. Schmainda KM,
    3. Weisskoff RM

    . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006; 27: 859– 67

    Abstract/FREE Full Text
19. 19.↵
    1. van den Hauwe L,
    2. Parizel PM,
    3. Martin JJ,
    4. et al

    . Postmortem MRI of the brain with neuropathological correlation. Neuroradiology 1995; 37: 343– 49

    PubMed
20. 20.↵
    1. Burger PC,
    2. Heinz ER,
    3. Shibata T,
    4. et al

    . Topographic anatomy and CT correlations in the untreated glioblastoma multiforme. J Neurosurg 1988; 68: 698– 704

    CrossRefPubMedWeb of Science
21. 21.↵
    1. Zhang M,
    2. Olsson Y

    . Hematogenous metastases of the human brain: characteristics of peritumoral brain changes—a review. J Neurooncol 1997; 35: 81– 89

    CrossRefPubMed
22. 22.↵
    1. Strugar J,
    2. Rothbart D,
    3. Harrington W,
    4. et al

    . Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis. J Neurosurg 1994; 81: 560– 66

    CrossRefPubMedWeb of Science
23. 23.↵
    1. Sugahara T,
    2. Korogi Y,
    3. Shigematsu Y,
    4. et al

    . Perfusion-sensitive MRI of cerebral lymphomas: a preliminary report. J Comput Assist Tomogr 1999; 23: 232– 37

    CrossRefPubMed
24. 24.↵
    1. Liao W,
    2. Liu Y,
    3. Wang X,
    4. et al

    . Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009; 50: 217– 25

    CrossRefPubMed
25. 25.↵
    1. Hartmann M,
    2. Heiland S,
    3. Harting I,
    4. et al

    . Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003; 338: 119– 22

    CrossRefPubMedWeb of Science
26. 26.↵
    1. Price SJ,
    2. Jena R,
    3. Burnet NG,
    4. et al

    . Improved delineation of glioma margins and regions of infiltration with the use of diffusion tensor imaging: an image-guided biopsy study. AJNR Am J Neuroradiol 2006; 27: 1969– 74

    Abstract/FREE Full Text
27. 27.↵
    1. Grier JT,
    2. Batchelor T

    . Low-grade gliomas in adults. Oncologist 2006; 11: 681– 93

    Abstract/FREE Full Text